Logo image of CVR

CHICAGO RIVET & MACHINE CO (CVR) Stock Fundamental Analysis

NYSEARCA:CVR - NYSE Arca - US1680881026 - Common Stock - Currency: USD

12.12  +0.13 (+1.13%)

Fundamental Rating

3

CVR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 128 industry peers in the Machinery industry. No worries on liquidiy or solvency for CVR as it has an excellent financial health rating, but there are worries on the profitability. CVR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year CVR has reported negative net income.
In the past year CVR has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: CVR reported negative net income in multiple years.
In the past 5 years CVR reported 4 times negative operating cash flow.
CVR Yearly Net Income VS EBIT VS OCF VS FCFCVR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of -18.76%, CVR is doing worse than 84.38% of the companies in the same industry.
Looking at the Return On Equity, with a value of -22.14%, CVR is doing worse than 79.69% of the companies in the same industry.
Industry RankSector Rank
ROA -18.76%
ROE -22.14%
ROIC N/A
ROA(3y)-10.44%
ROA(5y)-5.53%
ROE(3y)-11.91%
ROE(5y)-6.34%
ROIC(3y)N/A
ROIC(5y)N/A
CVR Yearly ROA, ROE, ROICCVR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

CVR has a worse Gross Margin (7.60%) than 91.41% of its industry peers.
CVR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CVR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.9%
GM growth 5Y-25.81%
CVR Yearly Profit, Operating, Gross MarginsCVR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

9

2. Health

2.1 Basic Checks

CVR does not have a ROIC to compare to the WACC, probably because it is not profitable.
CVR has about the same amout of shares outstanding than it did 1 year ago.
CVR has about the same amout of shares outstanding than it did 5 years ago.
CVR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CVR Yearly Shares OutstandingCVR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K
CVR Yearly Total Debt VS Total AssetsCVR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 4.33 indicates that CVR is not in any danger for bankruptcy at the moment.
The Altman-Z score of CVR (4.33) is better than 69.53% of its industry peers.
There is no outstanding debt for CVR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.33
ROIC/WACCN/A
WACC10%
CVR Yearly LT Debt VS Equity VS FCFCVR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 5.46 indicates that CVR has no problem at all paying its short term obligations.
CVR has a Current ratio of 5.46. This is amongst the best in the industry. CVR outperforms 92.97% of its industry peers.
CVR has a Quick Ratio of 2.53. This indicates that CVR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.53, CVR belongs to the best of the industry, outperforming 83.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.46
Quick Ratio 2.53
CVR Yearly Current Assets VS Current LiabilitesCVR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

0

3. Growth

3.1 Past

CVR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
Looking at the last year, CVR shows a very negative growth in Revenue. The Revenue has decreased by -13.88% in the last year.
The Revenue has been decreasing by -3.87% on average over the past years.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%157.45%
Revenue 1Y (TTM)-13.88%
Revenue growth 3Y-7.39%
Revenue growth 5Y-3.87%
Sales Q2Q%-7.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CVR Yearly Revenue VS EstimatesCVR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

0

4. Valuation

4.1 Price/Earnings Ratio

CVR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CVR Price Earnings VS Forward Price EarningsCVR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CVR Per share dataCVR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.00%, CVR has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.81, CVR has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.35, CVR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1%

5.2 History

The dividend of CVR decreases each year by -22.50%.
CVR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-22.5%
Div Incr Years0
Div Non Decr Years0
CVR Yearly Dividends per shareCVR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of CVR are negative and hence is the payout ratio. CVR will probably not be able to sustain this dividend level.
DP-5.56%
EPS Next 2YN/A
EPS Next 3YN/A
CVR Yearly Income VS Free CF VS DividendCVR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M

CHICAGO RIVET & MACHINE CO

NYSEARCA:CVR (7/11/2025, 8:04:00 PM)

12.12

+0.13 (+1.13%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-09 2025-05-09
Earnings (Next)08-11 2025-08-11
Inst Owners19.51%
Inst Owner Change0%
Ins Owners6.54%
Ins Owner Change0%
Market Cap11.76M
Analysts0
Price TargetN/A
Short Float %0.03%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield 1%
Yearly Dividend0.33
Dividend Growth(5Y)-22.5%
DP-5.56%
Div Incr Years0
Div Non Decr Years0
Ex-Date06-05 2025-06-05 (0.03)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.45
P/FCF N/A
P/OCF N/A
P/B 0.58
P/tB 0.58
EV/EBITDA N/A
EPS(TTM)-4.67
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.44
FCFYN/A
OCF(TTM)-1.82
OCFYN/A
SpS27.19
BVpS21.04
TBVpS21.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.76%
ROE -22.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.6%
FCFM N/A
ROA(3y)-10.44%
ROA(5y)-5.53%
ROE(3y)-11.91%
ROE(5y)-6.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.9%
GM growth 5Y-25.81%
F-Score3
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 51.49%
Cap/Sales 2.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.46
Quick Ratio 2.53
Altman-Z 4.33
F-Score3
WACC10%
ROIC/WACCN/A
Cap/Depr(3y)71.95%
Cap/Depr(5y)65.58%
Cap/Sales(3y)2.91%
Cap/Sales(5y)2.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%157.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.88%
Revenue growth 3Y-7.39%
Revenue growth 5Y-3.87%
Sales Q2Q%-7.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y32.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y37.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.17%
OCF growth 3YN/A
OCF growth 5YN/A